China Medicine Total Assets 2010-2010 | CHME

China Medicine total assets from 2010 to 2010. Total assets can be defined as the sum of all assets on a company's balance sheet.
China Medicine Annual Total Assets
(Millions of US $)
2009 $67
China Medicine Quarterly Total Assets
(Millions of US $)
2010-09-30 $134
2010-06-30 $135
2010-03-31 $139
2009-12-31 $67
2009-09-30 $53
2009-06-30 $47
2009-03-31 $46
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $0.000B $0.000B
China Medicine Corporation is a distributor of pharmaceutical and medical products, including prescription and over-the-counter drugs, Chinese herbs, traditional Chinese medicines made from Chinese herbs, nutritional supplements, dietary supplements, and medical instruments. The company is also engaged in proprietary research and development with the aim of creating new pharmaceutical products and intellectual property that it may sell in the future. China Medicine Corporation also sells improved drug formulas after purchasing the rights to drug formulas at an early stage of development and improving those formulas through its own research. The company's mission is to become a leading research-driven pharmaceutical company in China dedicated to the discovery, development, distribution and manufacturing of pharmaceutical products and nutritional supplements.
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) Israel $18.707B 6.68
Dr Reddy's Laboratories (RDY) India $12.148B 22.05
BridgeBio Pharma (BBIO) United States $8.716B 0.00
Bausch Health Cos (BHC) Canada $2.339B 1.69
Supernus Pharmaceuticals (SUPN) United States $1.861B 15.10
Amphastar Pharmaceuticals (AMPH) United States $0.999B 6.71
Personalis (PSNL) United States $0.548B 0.00
Taysha Gene Therapies (TSHA) United States $0.543B 0.00
Assembly Biosciences (ASMB) United States $0.139B 0.00
Sol-Gel Technologies (SLGL) Israel $0.023B 0.00
Evoke Pharma (EVOK) United States $0.007B 0.00
Teligent (TLGT) United States $0.000B 0.00